Brief: Grand Pharmaceutical Expects FY Profit Attributable HK$1.20 Bln-HK$1.25 Bln
20/03/2026 15:27
March 20 (Reuters) - Grand Pharmaceutical Group Ltd 0512.HK: EXPECTS FY2025 PROFIT ATTRIBUTABLE OF HK$1.20 BILLION-HK$1.25 BILLION EXPECTS FY2025 REVENUE OF HK$12.0 BILLION-HK$12.5 BILLION EXPECTED PROFIT DUE TO EQUITY INVESTMENTS OF GROUP LISTED OUTSIDE HK RECORDED FAIR VALUE LOSS IN FY Further company coverage: 0512.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Grand Pharmaceutical
See all newsBrief: Grand Pharmaceutical Group Declares No Interim Dividend Has Been Paid
Grand Pharmaceutical H1 revenue rises on nuclear medicine demand
Grand Pharma rises most in over a year as drug gets US FDA fast track designation
GPN01530-2 Granted Fast Track Designation By FDA
Brief: Grand Pharmaceutical Group Enters Huadong Medicine Supply Agreement